Here, we focused on the synergism between CDK4/6 inhibitors and TMZ, and report for the first time that abemaciclib and TMZ combination is more effective in inhibition of tumour cell proliferation and apoptotic induction in comparison with TMZ or abemaciclib singly. Here, CDK4 is linked to neoplasm.